Related Experiment Video
Updated: Jan 17, 2026

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy
Published on: January 10, 2019
Glucocorticoid-induced Thyrotoxic Periodic Paralysis Following Lumbar Nerve Root Block
Saki Uda1, Hayato Shimizu1, Hiroaki Nishioka1
1Department of General Internal Medicine, Kobe City Medical Center General Hospital, Japan.
Glucocorticoid injections can rarely trigger thyrotoxic periodic paralysis (TPP), a condition causing hypokalemia and muscle weakness in hyperthyroid patients. This case highlights the need for awareness of this unusual TPP trigger.
Area of Science:
- Endocrinology
- Neurology
Background:
- Thyrotoxic periodic paralysis (TPP) is a rare but serious complication of hyperthyroidism.
- TPP typically presents with hypokalemia and acute muscle weakness, often affecting the lower limbs.
Purpose of the Study:
- To report a rare case of TPP triggered by glucocorticoid injection.
- To raise awareness among clinicians regarding glucocorticoid-induced TPP in hyperthyroid patients.
Main Methods:
- Case report of a patient with hyperthyroidism who developed acute muscle weakness after a glucocorticoid injection.
- Laboratory investigations including potassium levels and thyroid function tests.
- Clinical assessment and response to treatment.
Main Results:
- The patient presented with progressive lower limb weakness and confirmed hypokalemia and hyperthyroidism.
- Symptoms resolved with intravenous potassium administration.
- The patient was diagnosed with TPP triggered by the glucocorticoid injection.
Conclusions:
- Glucocorticoid injection is an uncommon but potential trigger for TPP.
- Clinicians should consider glucocorticoid-induced TPP in the differential diagnosis of muscle weakness in hyperthyroid patients.
- Awareness of diverse TPP triggers is crucial for timely diagnosis and management.
More Related Videos
06:26Author Spotlight: Unveiling the Potential of TUBE Technique in Spinal Surgery
Published on: November 17, 2023
04:33Spinal Hernia Repair and Cauda Equina Repositioning After Lumbar Decompression under Three-Dimensional Microscopy: A Case Report and Literature Review
Published on: November 8, 2024
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Local Anesthetics: Clinical Application as Spinal Anesthesia
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...